A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31831743.
- Also identified by DOI 10.1038/s41467-019-13475-w and PMC identifier 6908726.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Aberrant autophagy is a major risk factor for inflammatory diseases and cancer. However, the genetic basis and underlying mechanisms are less established. UVRAG is a tumor suppressor candidate involved in autophagy, which is truncated in cancers by a frameshift (FS) mutation and expressed as a shortened UVRAG<sup>FS</sup>. To investigate the role of UVRAG<sup>FS</sup> in vivo, we generated mutant mice that inducibly express UVRAG<sup>FS</sup> (iUVRAG<sup>FS</sup>). These mice are normal in basal autophagy but deficient in starvation- and LPS-induced autophagy by disruption of the UVRAG-autophagy complex. iUVRAG<sup>FS</sup> mice display increased inflammatory response in sepsis, intestinal colitis, and colitis-associated cancer development through NLRP3-inflammasome hyperactivation. Moreover, iUVRAG<sup>FS</sup> mice show enhanced spontaneous tumorigenesis related to age-related autophagy suppression, resultant β-catenin stabilization, and centrosome amplification. Thus, UVRAG is a crucial autophagy regulator in vivo, and autophagy promotion may help prevent/treat inflammatory disease and cancer in susceptible individuals.
Medical subject headings
- Autophagy
- Carcinogenesis
- Inflammation
- Mutation
- Tumor Suppressor Proteins